BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9807975)

  • 1. Pharmacokinetics of mitomycin C in pelvic stopflow infusion and hypoxic pelvic perfusion with and without hemofiltration: a pilot study of patients with recurrent unresectable rectal cancer.
    Guadagni S; Aigner KR; Palumbo G; Cantore M; Fiorentini G; Pozone T; Deraco M; Clerico M; Chaudhuri PK
    J Clin Pharmacol; 1998 Oct; 38(10):936-44. PubMed ID: 9807975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxic pelvic perfusion with mitomycin C using a simplified balloon-occlusion technique in the treatment of patients with unresectable locally recurrent rectal cancer.
    Guadagni S; Fiorentini G; Palumbo G; Valenti M; Russo F; Cantore M; Deraco M; Vaglini M; Amicucci G
    Arch Surg; 2001 Jan; 136(1):105-12. PubMed ID: 11146790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitomycin C hypoxic pelvic perfusion for unresectable recurrent rectal cancer: pharmacokinetic comparison of surgical and percutaneous techniques.
    Guadagni S; Fiorentini G; Clementi M; Palumbo P; Mambrini A; Masedu F
    Updates Surg; 2017 Sep; 69(3):403-410. PubMed ID: 28791628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic of intraarterial mitomycin C with extra corporeal detoxification in humans.
    Palumbo G; Pantaleoni GC; Guadagni S
    Clin Ter; 1999; 150(3):209-14. PubMed ID: 10528433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliation with a multimodality treatment including hypoxic pelvic perfusion for unresectable recurrent rectal cancer: outcomes based on a retrospective study.
    Guadagni S; Clementi M; Bencivenga M; Kusamura S; Fiorentini C; Masedu F
    Updates Surg; 2018 Dec; 70(4):441-447. PubMed ID: 30191532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stop-flow technique for loco-regional delivery of high dose chemotherapy in the treatment of advanced pelvic cancers.
    Strocchi E; Iaffaioli RV; Facchini G; Mantovani G; Ricci S; Cavallo G; Tortoriello A; D'Angelo R; Formato R; Rosato G; Fiore F; Iaccarino V; Petrella G; Memoli B; Santangelo M; Camaggi CM
    Eur J Surg Oncol; 2004 Aug; 30(6):663-70. PubMed ID: 15256242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxic pelvic perfusion with cisplatin and mitomycin C in multidisciplinary palliative treatment of patients with unresectable recurrent rectal cancer: a retrospective study.
    Guadagni S; Fiorentini G; Palumbo P; Masedu F; Ricevuto E; Bruera G; Deraco M; Kusamura S; Sarti D; Fiorentini C; Gailhofer S; Clementi M
    Minerva Chir; 2019 Aug; 74(4):304-312. PubMed ID: 31062943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraaortic stop-flow infusion: pharmacokinetic feasibility study of regional chemotherapy for unresectable gastrointestinal cancers.
    Averbach AM; Stuart OA; Sugarbaker TA; Stephens AD; Fernandez-Trigo V; Shamsa F; Sugarbaker PH
    Ann Surg Oncol; 1995 Jul; 2(4):325-31. PubMed ID: 7552622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique.
    Turk PS; Belliveau JF; Darnowski JW; Weinberg MC; Leenen L; Wanebo HJ
    Arch Surg; 1993 May; 128(5):533-8; discussion 538-9. PubMed ID: 7683872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic studies of intraaortic stop-flow infusion with 14C-labeled mitomycin C.
    Averbach AM; Stuart OA; Sugarbaker TA; Stephens AD; Fernandez-Trigo V; Shamsa F; Sugarbaker PH
    J Surg Res; 1995 Sep; 59(3):415-9. PubMed ID: 7643602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the antineoplastic drug mitomycin C in regional chemotherapy using the aortic stop flow technique in advanced pancreatic carcinoma.
    Meyer F; Ridwelski K; Gebauer T; Grote R; Martens-Lobenhoffer J; Lippert H
    Chemotherapy; 2005 Mar; 51(1):1-8. PubMed ID: 15722626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of intra-arterial mitomycin C in the chemoembolization treatment of liver metastases with polyvinylalcohol or degradable starch microspheres.
    Rump AF; Woschée U; Theisohn M; Fischbach R; Heindel W; Lackner K; Klaus W
    Eur J Clin Pharmacol; 2002 Oct; 58(7):459-65. PubMed ID: 12389068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-arterial infusion chemotherapy in rectal cancer.
    Duprat G; Chalaoui J; Sylvestre J; Simard P; Roy P; Potvin C; Cantin J; Robidoux A
    Can J Surg; 1984 Jan; 27(1):57-9. PubMed ID: 6432303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antineoplastic perfusion with percutaneous stop-flow control in the treatment of advanced pelvic malignant neoplasms].
    De Santis M; Ariosi P; Calò GF; Luppi G; Franchini M; Romagnoli R
    Radiol Med; 2000; 100(1-2):56-61. PubMed ID: 11109453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic perfusion for locally recurrent unresectable rectal tumors.
    Unal AE; Bayar S; Tez M; Gocmen E; Kocaoglu H; Akgul H
    Hepatogastroenterology; 2005; 52(63):757-60. PubMed ID: 15966199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic intra-arterial mitomycin C infusion in previously treated patients with metastatic, unresectable, pelvic colorectal cancer and angiographic determination of tumor vascularity.
    Tseng MH; Park HC
    J Clin Oncol; 1985 Aug; 3(8):1093-100. PubMed ID: 3926959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloon-occlusion technique.
    Wanebo HJ; Chung MA; Levy AI; Turk PS; Vezeridis MP; Belliveau JF
    Ann Surg Oncol; 1996 May; 3(3):295-303. PubMed ID: 8726186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated pelvic perfusion for the treatment of unresectable primary or recurrent rectal cancer.
    Vaglini M; Cascinelli F; Chiti A; Deraco M; Inglese MG; Rebuffoni G; Rizzi M; Sala B; Santoro N; Santinami M
    Tumori; 1996; 82(5):459-62. PubMed ID: 9063524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Initial locoregional chemotherapy in recurrent and locoregional advanced or inoperable stages of pelvic uterine and anorectal cancers].
    Manivit P; Polo R; Tabary D; Nabet M; Polo M; Adamy M; Rubini B; Fromaget JM; Chipponi PN; Untereiner M
    Bull Cancer; 1995 Jan; 82(2):137-48. PubMed ID: 10846531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppository administration of chemotherapeutic drugs with concomitant radiation for rectal cancer.
    Pokorny RM; Wrightson WR; Lewis RK; Paris KJ; Hofmeister A; LaRocca R; Myers SR; Ackerman D; Galandiuk S
    Dis Colon Rectum; 1997 Dec; 40(12):1414-20. PubMed ID: 9407977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.